Article Sidebar
Views PDF: 134
Initial study of whole-body MRI value in assessement of lung cancer staging
Main Article Content
Abstract
SUMMARY
Purpose: This study aims to describe the characteristic of the primary and mestastasis lesions of pulmonary cancer on wholebody MRI and to study the value of whole-body MRI in assessement of pulmonary tumor staging.
Materials and methods: Prospective and describe study included 46 patients, confirmed of lung cancer base on histopathology, from January to October 2011 in Bach Mai Hospital. All of them were done whole-body MRI and 21 patients in which were taken FDG-PET/CT. The imaging characteristic of original tumor and metastasis lesions were describe on whole-body MRI. Assessement of lung cancer staging on whole-body MRI was compared with FDG-PET/CT.
Results: The mean diameter of original tumor is about 44.4±22.15mm. The average restriction of lung cancer is about 4.02±0.83 points. 67.5% of lung cancer presented mediastinal and pleural invasion. The metastasis rate of lymph node, bone, brain, liver and adrenal gland were 54.3%; 28.3%; 26.1%; 15.2% and 8.6% respectively. Assessement of lung cancer staging according to T, N, M and TNM between 2 methods of whole-body MRI and FDG-PET/CT with Kappa coefficence were 0.601; 0.516; 0.904 and 0.846 respectively, p < 0.05.
Conclusion: High field whole-body MRI were considered as an alternative modality to assess the lung cancer staging.
Article Details
References
1. Mai Trọng Khoa, T.Đ.H.v.c.c.s. (2010), “Giá trị của PET/CT trong chẩn đoán ung thư phổi không tế bào nhỏ”. Tạp chí Ung thư Bạch Mai.
2. Antoch, G., et al. (2003), “Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology”. JAMA. 290(24): p. 3199-206.
3. Gdeedo, A., et al. (1997), “Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma”. Eur J Cardiothorac Surg. 12(2): p. 224-7.
4. Kinkel, K., et al. (2002), “Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis”. Radiology. 224(3): p. 748-56.
5. Ohno, Y., et al. (2008), “Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT”. Radiology. 248(2): p. 643-54.
6. Plathow, C., et al. (2008), “Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer--initial results”. Invest Radiol. 43(5): p. 290-7.
7. Taneja, S. (2007), “Incidence of Asymptomatic Brain Metastasis in Lung Cancer Patients at initial Staging Work-up – a Study of 211 Cases”.
8. Yang F., et al. (2010), “Relationship between tumor size and disease stage in non-small cell lung cancer”. BMC Cancer. 10: p. 1-6.
9. Yi, C.A., et al. (2008), “Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging”. Radiology. 248(2): p. 632-42.